Anteris Technologies Global Corp. (AVR) Financial Statements
Industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies
In fiscal 2025, Anteris Technologies Global reported revenue of $1.9M. Net income was -$94.1M (a -4921.3% net margin), or -$2.55 per diluted share. Gross margin was 70.3% and operating margin was -4908.2%. Operating activities generated -$77.8M of cash, leaving -$79.8M of free cash flow. At fiscal year end, Anteris Technologies Global held $23.0M in total assets against $23.2M in total liabilities.
Open the full interactive Anteris Technologies Global financials → Quarterly statements, key ratios, valuation history and price charts.
Anteris Technologies Global Key Stats
| Share Price | $6.45 |
|---|---|
| Market Cap | $627.8M |
| 52-Week Range | $3.38 – $10.57 |
| Shares Outstanding | 97.3 million (basic, 2026 Q2) |
Anteris Technologies Global Income Statement
| FY 2025 | |
|---|---|
| Revenue | $1.9M |
| Cost of Goods Sold | $569,000 |
| Gross Profit | $1.3M |
| Operating Income | -$93.9M |
| Pre-Tax Income | -$94.2M |
| Income Tax | $0 |
| Net Income | -$94.1M |
| Diluted EPS | -$2.55 |
Anteris Technologies Global Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $429,000 | $310,000 | $494,000 | $1.0M |
| Net Income | -$22.2M | -$29.2M | -$23.0M | -$29.1M |
| Diluted EPS | -$0.62 | -$0.79 | -$0.28 | -$0.30 |
Anteris Technologies Global Balance Sheet
| FY 2025 | |
|---|---|
| Current Assets | $15.7M |
| Total Assets | $23.0M |
| Current Liabilities | $21.4M |
| Total Long-Term Debt | $38,000 |
| Total Liabilities | $23.2M |
| Shareholders' Equity | -$93,000 |
Anteris Technologies Global Cash Flow Statement
| FY 2025 | |
|---|---|
| Cash From Operations | -$77.8M |
| Cash From Investing | -$596,000 |
| Cash From Financing | $20.6M |
| Free Cash Flow | -$79.8M |
Figures from Anteris Technologies Global's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Anteris Technologies Global financials page for every line item.
Anteris Technologies Global Company Profile
| Ticker | AVR |
|---|---|
| Exchange | Nasdaq |
| Industry | Orthopedic, Prosthetic & Surgical Appliances & Supplies |
| Headquarters | Eagan, Minnesota |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Emerging growth company |
| SEC CIK | 0002011514 |
Frequently Asked Questions
What was Anteris Technologies Global's revenue in fiscal 2025?
Anteris Technologies Global (AVR) reported revenue of $1.9M for fiscal 2025.
What was Anteris Technologies Global's net income in fiscal 2025?
Anteris Technologies Global reported net income of -$94.1M for fiscal 2025.
What was Anteris Technologies Global's earnings per share (EPS) in fiscal 2025?
Anteris Technologies Global's diluted EPS was -$2.55 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Anteris Technologies Global generate in fiscal 2025?
Anteris Technologies Global generated -$79.8M of free cash flow in fiscal 2025.
What was Anteris Technologies Global's revenue last quarter?
In its most recent reported quarter (2026 Q2), Anteris Technologies Global reported revenue of $1.0M.
How much debt does Anteris Technologies Global have?
Anteris Technologies Global reported $38,000 of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Anteris Technologies Global are outstanding?
Anteris Technologies Global reported a weighted average of 97.3 million basic shares outstanding in 2026 Q2.
What is Anteris Technologies Global's market cap?
Based on its latest closing price, Anteris Technologies Global (AVR) has a market capitalization of about $627.8M.
When does Anteris Technologies Global's fiscal year end?
Anteris Technologies Global's fiscal year end, as registered with the SEC, is December 31.
Where is Anteris Technologies Global headquartered?
Anteris Technologies Global lists its business address in Eagan, Minnesota in its SEC filings.
Anteris Technologies Global Competitors & Similar Companies
See all 20 Orthopedic, Prosthetic & Surgical Appliances & Supplies companies →